Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Aehr Test Systems: The FY2027 Rebound Is Real, But The Price Asks For Too Much (AEHR)

22 August 2026

Neurocrine Biosciences Stock: ‘House Full Of Options’ (NASDAQ:NBIX)

22 August 2026

KORU Medical Systems Stock Selloff Offers An Opportunity (NASDAQ:KRMD)

22 August 2026

Eikon Therapeutics, Inc. (EIKN) Discusses Advances in PARP1 Biology and Next-Generation PARP Inhibitors in Oncology Transcript

22 August 2026

Drug kingpin jailed after fleeing to Dubai and five years on the run

22 August 2026
Facebook X (Twitter) Instagram
Business Saturday, Aug 22
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » Neurocrine Biosciences Stock: ‘House Full Of Options’ (NASDAQ:NBIX)
News

Neurocrine Biosciences Stock: ‘House Full Of Options’ (NASDAQ:NBIX)

thebusinesstimes.co.ukBy thebusinesstimes.co.uk22 August 20260 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Share
Facebook Twitter LinkedIn Pinterest Email

This article was written by

Curiosity is my middle name. I started my career as a fixed-income quant focusing on Polish bonds, later expanding into US Treasuries, before transitioning to the equity side as one of the youngest pension fund managers in Poland, running the equity book mostly single-handedly at the age of 25. A few years later, after delivering strong results, I experienced burnout and chose to spend a decade as a full-time private investor, focusing on major stock indices and commodity futures. I then returned to the institutional side, spending seven years managing a global listed REITs alternative fund for a Luxembourg-based boutique. While the investment track record was excellent, asset growth was sluggish, and with the outlook for REITs in 2024 looking average at best, I decided to pivot. Today, I dive deep into secular technology trends on my own—specifically the AI revolution, space tech, quantum computing, and biotechnology. I am here on Seeking Alpha to share my research, investment ideas, and financial models. While I am not a native English speaker, I let the quality of my numbers do the talking. My modeling approach is strictly conservative (often highly so); over 30 years of market experience have taught me that incorporating a wide margin of safety is vital, as market anomalies and negative surprises happen far more often than most people, and especially analysts, like to admit.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Aehr Test Systems: The FY2027 Rebound Is Real, But The Price Asks For Too Much (AEHR)

KORU Medical Systems Stock Selloff Offers An Opportunity (NASDAQ:KRMD)

Eikon Therapeutics, Inc. (EIKN) Discusses Advances in PARP1 Biology and Next-Generation PARP Inhibitors in Oncology Transcript

Drug kingpin jailed after fleeing to Dubai and five years on the run

Enovix Stock Is At The Lows For Good Reason (NASDAQ:ENVX)

Pony AI Inc. 2026 Q2 – Results – Earnings Call Presentation (NASDAQ:PONY) 2026-08-21

Kuaishou: The AI Potential Vs. Advertising Reality (OTCMKTS:KUASF)

Banca Monte dei Paschi di Siena S.p.A. (BMPSY) Discusses Strategic Merger to Create Leading Italian Banking and Wealth Management Group Transcript

Helus Pharma: An Undervalued Psychedelic Platform Approaching A Major Catalyst

Editors Picks

Neurocrine Biosciences Stock: ‘House Full Of Options’ (NASDAQ:NBIX)

22 August 2026

KORU Medical Systems Stock Selloff Offers An Opportunity (NASDAQ:KRMD)

22 August 2026

Eikon Therapeutics, Inc. (EIKN) Discusses Advances in PARP1 Biology and Next-Generation PARP Inhibitors in Oncology Transcript

22 August 2026

Drug kingpin jailed after fleeing to Dubai and five years on the run

22 August 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

Enovix Stock Is At The Lows For Good Reason (NASDAQ:ENVX)

22 August 2026

Pony AI Inc. 2026 Q2 – Results – Earnings Call Presentation (NASDAQ:PONY) 2026-08-21

22 August 2026

Kuaishou: The AI Potential Vs. Advertising Reality (OTCMKTS:KUASF)

21 August 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.